GlassScriptPhysician profile
Adam Chodosh
NPI 1376769364
$6,741.01
in general payments reported to CMS, 2019-2025
9 companies · $588 in 2025
The $588 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,486 · 2020: $214 · 2021: $87.74 · 2022: $333 · 2023: $3,471 · 2024: $561 · 2025: $588.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,743 · Food and Beverage: $1,877.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,743.12 |
| Food and Beverage | $1,876.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,880.79 | 2019-2025 | Aveir, Ensite, Tacticath Ablation Catheter, Sensor Enabled |
| Medtronic Vascular, INC. | $1,077.25 | 2019 | |
| Medtronic, INC. | $290.98 | 2023-2024 | Arctic Front Advance, Launcher |
| Boston Scientific Corporation | $189.84 | 2020-2025 | Lux-Dx Insertable Cardiac Monitor, Ingevity+, Farapulse |
| Biosense Webster, INC. | $132.63 | 2025 | Carto 3 |
| Cardiva Medical, INC. | $72.50 | 2021-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Optowire |
| Philips North America LLC | $37.03 | 2025 | Igt Devices Undivided |
| Terumo Medical Corporation | $31.89 | 2025 | Heartrail, Metacross Otw |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $28.10 | 2023 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Chodosh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.